Merck & Co Inc investor relations material
Merck & Co., Inc. offers healthcare products worldwide. The company operates in two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers medicines and vaccines for human health conditions across a range of diseases. Its products include consumer- and hospital-based solutions for antibacterial therapies; vaccines for bacterial infections (including meningitis, pneumonia and influenza); vaccines for viral infections (including cervical cancer, hepatitis and shingles); mental health therapies; anticancer therapies; anti-inflammatory solutions; products to manage coagulation disorders and cardiovascular disorders (including high cholesterol); antimicrobial production solutions; transplantation solutions; and respiratory solutions comprising treatments for bronchopulmonary disorders. It also develops biologic products to treat patients suffering with immune-inflammatory conditions; biosimilars; and therapeutics that support the immune system. The Animal Health segment markets animal health vaccines and medications, antimicrobials, parasiticides, insecticides, dewormers, anti-infectives, anthelmintics and medicated feed additives. It serves veterinarians, livestock producers and distributors of pet food.